Therapeutic Drug Monitoring: A Review
Abstract
Therapeutic drug monitoring (TDM) is well known for adjusting a patient’s medication dose such that the level of drug in their blood remains within a therapeutic range. TDM requires the concentration of a medication to be measured in a variety of physiological fluids.The method by which the medicine is manufactured also has an impact, because certain synthesised pharmaceuticals behave differently in the body than their licenced counterparts. TDM is one of the numerous areas where pharmacoeconomics is now being used. This is happening as both physicians and the general public grow increasingly worried about rising health-care expenses and the preparedness that has been identified as a consequence of using TDM. TDM helps in minimising risk while taking drugs like digoxin, aminoglycosides and various other drugs with narrow therapeutic index. TDM helps in identifying safer drug and dose of a drug by analysing the effects of the drug. TDM is used to ensure that the dosage of medication that you are taking is safe and effective. TDM is the clinical practice that monitors a drug’s or its metabolite’s concentration to guide personalized dosing with the goal of achieving a concentration target that is related to a desired treatment outcome.
Keywords: Therapeutic drug monitoring, vancomycin, aminoglycosides, digitalis, adverse effects.
Keywords:
Therapeutic drug monitoring, vancomycin, aminoglycosides, digitalis, adverse effectsDOI
https://doi.org/10.22270/jddt.v13i10.6251References
Kang JS, Lee MH. Overview of therapeutic drug monitoring. The Korean journal of internal medicine. 2009(1):1. https://doi.org/10.3904/kjim.2009.24.1.1 PMid:19270474 PMCid:PMC2687654
Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PloS one. 2013;8(10):e77169. https://doi.org/10.1371/journal.pone.0077169 PMid:24204764 PMCid:PMC3799644
Zhang D, Chow DS. Clinical pharmacokinetics of mycophenolic acid in hematopoietic stem cell transplantation recipients. European journal of drug metabolism and pharmacokinetics. 2017;42:183-9. https://doi.org/10.1007/s13318-016-0378-6 PMid:27677732
Jensen SA, Dalhoff KP. Therapeutic monitoring by blood concentrations with the focus on cyclosporin A. Ugeskrift for Laeger. 2001;163(14):2009-12.
Kang JS, Lee MH. Overview of therapeutic drug monitoring. The Korean journal of internal medicine. 2009 ;24(1):1. https://doi.org/10.3904/kjim.2009.24.1.1 PMid:19270474 PMCid:PMC2687654
Visser M. Techniques for Monitoring Drug Efficacy. Veterinary Clinics: Exotic Animal Practice. 2018;21(2):287-95. https://doi.org/10.1016/j.cvex.2018.01.003 PMid:29655470
Kang JS, Lee MH. Overview of therapeutic drug monitoring. The Korean journal of internal medicine. 2009;24(1):1. https://doi.org/10.3904/kjim.2009.24.1.1 PMid:19270474 PMCid:PMC2687654
Bochner F, Tonkin A. The clinician and therapeutic drug monitoring in the 1990s. Medical journal of Australia. 1993;158(6):422-6. https://doi.org/10.5694/j.1326-5377.1993.tb121842.x PMid:8479359
Aronson JK, Hardman M. ABC of monitoring drug therapy. Measuring plasma drug concentrations. BMJ: British Medical Journal. 1992 ;305(6861):1078. https://doi.org/10.1136/bmj.305.6861.1078 PMid:1467691 PMCid:PMC1883634
Cristodorescu R, Deutsch G, Drăgan S. Clinical utility of plasma digoxin measurements. Medecine Interne. 1989;27(1):25-32.
Schumacher GE, Barr JT. Economic and outcome issues for therapeutic drug monitoring in medicine. Therapeutic drug monitoring. 1998;20(5):539-42. https://doi.org/10.1097/00007691-199810000-00016 PMid:9780132
Schumacher GE, Barr JT. Total testing process applied to therapeutic drug monitoring: impact on patients' outcomes and economics. Clinical Chemistry. 1998;44(2):370-4. https://doi.org/10.1093/clinchem/44.2.370
Darko W, Medicis JJ, Smith A, Guharoy R, Lehmann DF. Mississippi mud no more: cost‐effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2003;23(5):643-50. https://doi.org/10.1592/phco.23.5.643.32199 PMid:12741439
Touw DJ, Neef C, Thomson AH, Vinks AA. Cost-effectiveness of therapeutic drug monitoring: a systematic review. Therapeutic drug monitoring. 2005 ;27(1):10-7. https://doi.org/10.1097/00007691-200502000-00004 PMid:15665740
Published
Abstract Display: 627 
PDF Downloads: 526 PDF Downloads: 33 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.